Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Want to make money from home? Discover simple and effective ways to earn cash quickly without leaving your house.
24,232 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
When market sentiment turns sour, investors watch a single metric for clues. This article breaks down what this stock...
As market rallies surge, the Goldman Sachs Nasdaq-100 Premium Income ETF trails the upside. Retirees, however, keep b...
When a high-profile investor makes a big move, questions follow. This guide cuts through the headlines to examine Ali...
AppLovin rode a massive multi-year rally, but a pivot to pure-play ad tech and a softening macro beat have investors ...
Warren Buffett publicly stated he initiated Berkshire Hathaway’s larger stake in Alphabet, signaling a top-down push ...
Snowflake reported a stronger-than-expected quarter, with revenue and EPS above estimates and AI-driven monetization ...
A sharp February move put Remitly Global in the spotlight. This article breaks down the catalysts behind the rally, t...
A recent move shows Bamco expanding its exposure to FactSet, highlighting the power of subscription-based data platfo...
Northrop Grumman has surged in 2026 on a record backlog and strong cash flow, but a major program in limbo keeps inve...
Wells Fargo and Jefferies boosted ONEOK on Wednesday, citing a structural shift in energy demand tied to Iran-related...
Strategy unveils a private repurchase of roughly $1.5 billion in convertible notes, funded by cash, ATM proceeds, and...